CH EMED EPR
2.0.0 - trial-use
This page is part of the FHIR eMedication exchange formats for the implementation effort of CARA within its EPR community (v2.0.0: STU2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Generated Narrative: Observation ObservationTriatecPml
CH EMED Extension Treatment Plan
- id: Uniform Resource Identifier (URI)/urn:uuid:41b97645-e263-47c2-8d96-79da451a33f2
- externalDocumentId: Uniform Resource Identifier (URI)/urn:uuid:24c84eef-f9db-4710-8f6c-2d342ad3ac2d
CH EMED Extension MedicationStatement Changed: Bundle: identifier = UUID:7042ee91-a485-47cb-94fa-a1c2f0ef2dbc; type = document; timestamp = 2023-04-21 09:21:54+0200
CH EMED Extension Pharmaceutical Advice
- id: Uniform Resource Identifier (URI)/urn:uuid:41b97645-e263-47c2-8d96-79da451a33f2
- externalDocumentId: Uniform Resource Identifier (URI)/urn:uuid:293bf5b1-f663-4914-8080-4e33aa54b909
identifier: Uniform Resource Identifier (URI)/urn:uuid:e729b2f6-62aa-4628-8a13-27c8b8674473
status: Final
code: CHANGE
issued: 2023-04-11 12:00:00+0200
note: Changed intake to range 0.5-1 tablets after discussion with patient.